Connect with us
A new study is shedding light on the benefits of getting a fourth COVID-19 vaccine dose or a second booster amid the ongoing pandemic. The findings...
COVID-19 vaccine makers are shifting gears and planning for a smaller, more competitive booster shot market after delivering as many doses as fast as they could...
As different variants and subvariants continue to emerge, a leading scientist believes the next step is to create a vaccine that stops transmissions. Sir John Bell,...
As the fourth COVID-19 vaccine dose has started to roll out in more countries, doubts remain on whether or not the extra jab would be necessary....
BA.4, BA.5 variants sweeping South Africa have been detected in the U.S., with the potential to start another COVID wave | Fortune You need to enable...
Moderna asks the FDA to authorize low doses of its COVID vaccine for kids under 6 | Fortune You need to enable JavaScript to view this...
How Hewlett Packard Enterprise used A.I.-driven data to accelerate COVID vaccine research | Fortune You need to enable JavaScript to view this site.
The third dose of the Pfizer vaccine may provide sufficient protection against omicron and other SARS-CoV-2 variants, but it is not for long term. Research has...
Vaccine maker Novavax announced Wednesday that its combination vaccine that targets COVID-19 and the flu provided a strong immune response based on early data conducted. According...
Novavax stock drops even after Japan approves its non-mRNA COVID vaccine | Fortune You need to enable JavaScript to view this site.
Recent Comments